Skip to main content

Logo ^ A66 Pill - clear white capsule/oblong

Pill with imprint Logo ^ A66 is Clear / White, Capsule/Oblong and has been identified as Topiramate 15 mg. It is supplied by Advagen Pharma Ltd.

Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo ^ A66

Topiramate

Imprint
Logo ^ A66
Strength
15 mg
Color
Clear / White (clear transparent cap and white opaque body)
Shape
Capsule/Oblong (hard gelatin capsule filled with off white to beige pellets)
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Advagen Pharma Ltd.
Manufacturer
Rubicon Research Private Limited
National Drug Code (NDC)
72888-0228

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.